Gå offline med appen Player FM !
Accum™ technology in early cancer trials and beyond
Manage episode 396307526 series 2680968
Many of the latest anti-cancer drugs are targeted towards the tiniest molecular differences in cells. But even if you know the genetic make up of a tumour, getting medicines to - and then in to - the affected area is a different challenge.
Dr Moutih Rafei at Defence Therapeutics reports on a novel drug technology that gets more treatment to the cells that need it, and what that might mean for the future of designing, trialling, and marketing medicines.
Read the original research: https://doi.org/10.1111/cas.15985
371 episoder
Manage episode 396307526 series 2680968
Many of the latest anti-cancer drugs are targeted towards the tiniest molecular differences in cells. But even if you know the genetic make up of a tumour, getting medicines to - and then in to - the affected area is a different challenge.
Dr Moutih Rafei at Defence Therapeutics reports on a novel drug technology that gets more treatment to the cells that need it, and what that might mean for the future of designing, trialling, and marketing medicines.
Read the original research: https://doi.org/10.1111/cas.15985
371 episoder
Alla avsnitt
×Välkommen till Player FM
Player FM scannar webben för högkvalitativa podcasts för dig att njuta av nu direkt. Den är den bästa podcast-appen och den fungerar med Android, Iphone och webben. Bli medlem för att synka prenumerationer mellan enheter.